Indication
For the treatment of moderate or severe postnatal depression (PND) in adults following childbirth.
Medicine details
- Medicine name:
- zuranolone (Zurzuvae)
- SMC ID:
- SMC2862
- Pharmaceutical company
- Biogen
- BNF chapter
- Central nervous system
- Submission type
- Full
- Publication due date:
- 09 February 2026
- SMC meeting date:
- 13 January 2026
- Patient group submission deadline:
- TBC